Related Experiment Videos
Systemic herpes simplex infection with fulminant hepatitis post-transplantation
Australian and New Zealand Journal of Medicine
|December 1, 1976
Summary
Renal transplant patients on immunosuppression face severe infections. A fatal case of herpes simplex virus (HSV) hepatitis in a transplant recipient highlights the risks and treatment challenges of this severe infection.
Area of Science:
- Nephrology
- Virology
- Immunology
Background:
- Immunosuppression after renal transplantation increases susceptibility to opportunistic infections.
- Herpes simplex virus (HSV) can cause severe, fatal hepatitis in immunocompromised individuals.
Observation:
- A case of fatal HSV hepatitis following renal transplantation is presented.
- The patient's condition did not improve with cytosine arabinoside treatment.
Findings:
- Fulminant hepatitis due to HSV infection can be a life-threatening complication in renal transplant recipients.
- Standard antiviral treatment may be ineffective in severe cases.
Implications:
- Highlights the critical need for vigilant monitoring and prompt diagnosis of HSV infections in transplant patients.
- Suggests potential limitations of current antiviral therapies for severe HSV hepatitis in this population.